We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Interactive Computer Treatment for Panic Disorder

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00063375
First Posted: June 27, 2003
Last Update Posted: October 25, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute of Mental Health (NIMH)
Information provided by:
Florida State University
  Purpose
This study will develop an interactive computer-based version of cognitive behavioral therapy (CBT) and compare its effectiveness to book-based CBT for the treatment of panic disorder.

Condition Intervention Phase
Panic Disorder Behavioral: Computer Based Cognitive Behavioral Therapy Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Interactive Computer Treatment for Panic Disorder

Resource links provided by NLM:


Further study details as provided by Florida State University:

Estimated Enrollment: 60
Study Start Date: January 2002
Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)
Detailed Description:

Panic disorder (PD) is a highly prevalent and debilitating condition. Unfortunately, many people with PD go untreated because of the high cost and low availability of treatment. Research shows that CBT is an effective treatment for PD. When administered as a self-help, computer based treatment, CBT may provide a less expensive, more engaging treatment for PD.

Participants in this study will be randomly assigned to receive computer based treatment, book based treatment, or no treatment for 10 weeks. After these 10 weeks, symptoms of anxiety and depression will be measured with patient interviews, scales, and questionnaires.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • DSM-IV diagnosis of panic disorder, with or without agoraphobia

Exclusion Criteria:

  • Change in medication type or dose 12 weeks prior to study entry
  • Suicidal
  • Current substance abuse
  • Current or past schizophrenia, bipolar disorder, or organic mental disorder. Patients on medications must meet stability requirements such that initial administration of the medication and dose has been maintained for at least 3 months prior to treatment and will be maintained until post-treatment.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00063375


Locations
United States, Florida
Florida State University
Tallahassee, Florida, United States, 32306
Sponsors and Collaborators
Florida State University
National Institute of Mental Health (NIMH)
  More Information

ClinicalTrials.gov Identifier: NCT00063375     History of Changes
Other Study ID Numbers: R21MH062056 ( U.S. NIH Grant/Contract )
DSIR AT-AS
First Submitted: June 25, 2003
First Posted: June 27, 2003
Last Update Posted: October 25, 2013
Last Verified: October 2013

Additional relevant MeSH terms:
Disease
Panic Disorder
Pathologic Processes
Anxiety Disorders
Mental Disorders